Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- Check3 days agoChange DetectedThe term 'Small cell lung carcinoma' was added to the list of tumor types. This aligns terminology but does not alter any study details or requirements.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedHepatocellular carcinoma was added to the list of study conditions. The page revision was updated to version 3.5.0.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedThe changes include a minor site revision to v3.4.2 and the removal of the government funding status notice (and Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedA new funding-status notice has been added to the page, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page metadata/footer now includes a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' label, and a new 'Revision: v3.4.0' tag, while the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.